Rasagiline Mesylate Tablet
Product Images NDC 71921-407

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Rasagiline Mesylate (NDC 71921-407). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Florida Pharmaceutical Products, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Rasagiline-container-1 (Rasagiline Container 1)

Label for Rasagiline Tablets 0.5 mg oral tablets, container of 30 tablets, prescription only. Manufactured by Indoco Remedies Ltd and labeled for Florida Pharmaceutical Products, LLC. Storage instructions and reference to accompanying prescribing information are provided. Includes NDC 71921-407-33 and barcodes.*

FDA Label Image

Rasagiline-container-2 (Rasagiline Container 2)

Label for Rasagiline Tablets 1 mg oral tablets in a package of 30 tablets. Manufactured by Indoco Remedies Ltd. for Florida Pharmaceutical Products, LLC. The label includes storage instructions, a child-resistant package notice, and two barcodes.*

FDA Label Image

Str (Str)

Chemical structure of Rasagiline mesylate, showing its molecular configuration with the indane moiety and mesylate group (CH3SO3H) attached.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.